These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32192229)

  • 1. Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-
    Zádor F; Mohammadzadeh A; Balogh M; Zádori ZS; Király K; Barsi S; Galambos AR; László SB; Hutka B; Váradi A; Hosztafi S; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32192229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14-O-Methylmorphine: A Novel Selective Mu-Opioid Receptor Agonist with High Efficacy and Affinity.
    Zádor F; Balogh M; Váradi A; Zádori ZS; Király K; Szűcs E; Varga B; Lázár B; Hosztafi S; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2017 Nov; 814():264-273. PubMed ID: 28864212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.
    Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy.
    Lacko E; Varadi A; Rapavi R; Zador F; Riba P; Benyhe S; Borsodi A; Hosztafi S; Timar J; Noszal B; Furst S; Al-Khrasani M
    Curr Med Chem; 2012; 19(27):4699-707. PubMed ID: 22934777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new potent analgesic agent with reduced liability to produce morphine tolerance.
    Kiraly K; Caputi FF; Hanuska A; Kató E; Balogh M; Köles L; Palmisano M; Riba P; Hosztafi S; Romualdi P; Candeletti S; Ferdinandy P; Fürst S; Al-Khrasani M
    Brain Res Bull; 2015 Aug; 117():32-8. PubMed ID: 26235542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Peripheral Versus Central Antinociception of a Novel Opioid Agonist: Acute Inflammatory Pain in Rats.
    Balogh M; Zádori ZS; Lázár B; Karádi D; László S; Mousa SA; Hosztafi S; Zádor F; Riba P; Schäfer M; Fürst S; Al-Khrasani M
    Neurochem Res; 2018 Jun; 43(6):1250-1257. PubMed ID: 29725918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, chemical synthesis, and biological evaluation of thiosaccharide analogues of morphine- and codeine-6-glucuronide.
    MacDougall JM; Zhang XD; Polgar WE; Khroyan TV; Toll L; Cashman JR
    J Med Chem; 2004 Nov; 47(23):5809-15. PubMed ID: 15509180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
    Cook CD; Nickerson MD
    J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation.
    Zhang T; Han Z; Shi X; Zhao W; Wang Z; Zhang R; Xu B; Zhang M; Zhang Q; Xiao J; Zhu H; Zheng T; Fang Q
    Bioorg Med Chem; 2019 Feb; 27(4):630-643. PubMed ID: 30626554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology.
    Zádor F; Király K; Váradi A; Balogh M; Fehér Á; Kocsis D; Erdei AI; Lackó E; Zádori ZS; Hosztafi S; Noszál B; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2017 Aug; 809():111-121. PubMed ID: 28502630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration.
    Lackó E; Riba P; Giricz Z; Váradi A; Cornic L; Balogh M; Király K; Csekő K; Mousa SA; Hosztafi S; Schäfer M; Zádori ZS; Helyes Z; Ferdinandy P; Fürst S; Al-Khrasani M
    J Pharmacol Exp Ther; 2016 Oct; 359(1):171-81. PubMed ID: 27435180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
    Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
    Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
    Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
    Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
    McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
    Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
    Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
    Negri L; Lattanzi R; Melchiorri P
    Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
    Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
    Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.